Meningococcal vaccine update

More than half a million doses of Sanofi’s meningococcal vaccine, Menactra, have arrived in Australia The vaccine is indicated for people from two through to 55 years, to protect against meningococcal disease caused by four groups of Neisseria meningitides—A, C, Y and W-135. Auspharm forum members discussed their problems accessing stock back in March. Russell